Showing results (551-560 of 563) with videos related to
Sort By:
Pageof 57
Cancer|December 1, 2024
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024Alan H Bryce, Neeraj Agarwal, Himisha Beltran, et al.Orphanet Journal of Rare Diseases|May 17, 2011
Complete exon sequencing of all known Usher syndrome genes greatly improves molecular diagnosisCrystel Bonnet, M'hamed Grati, Sandrine Marlin, et al.Plos Medicine|September 25, 2018
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trialBrian Lawlor, Ricardo Segurado, Sean Kennelly, et al.JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2Alan H Bryce, E David Crawford, Neeraj Agarwal, et al.The New England Journal of Medicine|August 27, 2023
OCT or Angiography Guidance for PCI in Complex Bifurcation LesionsNiels R Holm, Lene N Andreasen, Omeed Neghabat, et al.JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1E David Crawford, Alan H Bryce, Maha H Hussain, et al.Bulletin Du Cancer|February 28, 2024
[French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract - General principles of treatment]Béatrix Barry, Gilles Dolivet, Florian Clatot, et al.Neuroimage. Clinical|January 19, 2020
Altered resting-state dynamic functional brain networks in major depressive disorder: Findings from the REST-meta-MDD consortiumYicheng Long, Hengyi Cao, Chaogan Yan, et al.The Lancet. Oncology|March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort studyMadeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.JAMA Network Open|December 13, 2021
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate CancerMichael Xiang, Ting Martin Ma, Ricky Savjani, et al.Pageof 57